The effect of camicinal (GSK962040), a motilin agonist, on gastric emptying and glucose absorption in feed-intolerant critically ill patients: a randomized, blinded, placebo-controlled, clinical trial

Overview of attention for article published in Critical Care, August 2016

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 17 X posts from 15 X users, with an upper bound of 88,372 followers.

RT @Crit_Care: Camicinal (GSK962040), motilin agonist, on gastric emptying & glucose absorption in feed-intolerant ICU pts https://t.co/KY9…

RT @Crit_Care: Camicinal (GSK962040), motilin agonist, on gastric emptying & glucose absorption in feed-intolerant ICU pts https://t.co/KY9…

RT @Crit_Care: Camicinal (GSK962040), motilin agonist, on gastric emptying & glucose absorption in feed-intolerant ICU pts https://t.co/KY9…

RT @Crit_Care: Camicinal (GSK962040), motilin agonist, on gastric emptying & glucose absorption in feed-intolerant ICU pts https://t.co/KY9…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 13 additional X posts.